Adenoma-infiltrating Lymphocytes (AILs) are a potential marker of hereditary nonpolyposis colorectal cancer

American Journal of Surgical Pathology

Volumn 32, Issue 11, 2008, Pages 1661-1666

  Polydorides, Alexandros D ^a   Mukherjee, Bhramar ^a   Gruber, Stephen B ^a,b   McKenna, Barbara J ^a   Appelman, Henry D ^a   Greenson, Joel K ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Colorectal adenoma; HNPCC; Lymphocytes, apoptosis; Microsatellite instability

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER LOCALIZATION; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE MARKER; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MALE; MITOSIS; ADENOMA; COLORECTAL TUMOR; COMPARATIVE STUDY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; TUMOR ASSOCIATED LEUKOCYTE;

TUMOR MARKER;

ADENOMA; ADULT; AGED; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 56149092514     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31816ffa80     Document Type: Article

References (35)

1. Alexander J, Watanabe T, Wu TT, et al. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol. 2001;158:527-535.
2. Arai T, Kino I. Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J Pathol. 1995;176: 37-44.
3. de Jong AE, Morreau H, van Puijenbroek M, et al. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology. 2004;126:42-48.
4. de Jong AE, Morreau H, Nagengast FM, et al. Prevalence of adenomas among young individuals at average risk for colorectal cancer. Am J Gastroenterol. 2005;100:139-143.
5. Dolcetti R, Viel A, Doglioni C, et al. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol. 1999;154:1805-1813.
6. Gaglia P, Atkin WS, Whitelaw S, et al. Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancer. Gut. 1995;36:385-390.
7. Giuffre G, Muller A, Brodegger T, et al. Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection: correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis. J Mol Diagn. 2005;7:160-170.
8. Greenson JK, Bonner JD, Ben-Yzhak O, et al. Phenotype of microsatellite unstable colorectal carcinomas: well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol. 2003;27:563-570.
9. Halvarsson B, Lindblom A, Johansson L, et al. Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer. Mod Pathol. 2005;18:1095-1101.
10. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352:1851-1860.
11. Iino H, Simms L, Young J, et al. DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer. Gut. 2000;47:37-42.
12. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118: 829-834.
13. Johnson PM, Gallinger S, McLeod RS. Surveillance colonoscopy in individuals at risk for hereditary nonpolyposis colorectal cancer: an evidence-based review. Dis Colon Rectum. 2006;49:80-93.
14. Lindgren G, Liljegren A, Jaramillo E, et al. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut. 2002;50:228-234.
15. Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006;296:1507-1517.
16. Lynch HT, Smyrk T, Jass JR. Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas? Semin Surg Oncol. 1995;11:406-410.
17. Mecklin JP, Aarnio M, Läärä E, et al. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology. 2007;133:1093-1098.
18. Michael-Robinson JM, Biemer-Hüttmann A, Purdie DM, et al. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut. 2001;48:360-366.
19. Muller A, Beckmann C, Westphal G, et al. Prevalence of the mismatch-repair-deficient phenotype in colonic adenomas arising in HNPCC patients: results of a 5-year follow-up study. Int J Colorectal Dis. 2006;21:632-641.
20. Nomura M, Watari J, Yokota K, et al. Morphogenesis of nonpolypoid colorectal adenomas and early carcinomas assessed by cell proliferation and apoptosis. Virchows Arch. 2000;437:17-24.
21. Rijcken FE, Hollema H, Kleibeuker JH. Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut. 2002;50:382-386.
22. Rijcken FE, Koornstra JJ, van der Sluis T, et al. Early carcinogenic events in HNPCC adenomas: differences with sporadic adenomas. Dig Dis Sci. 2007 [Epub Nov 13].
23. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute Workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997;89:1758-1762.
24. Rubio CA. Intraepithelial lymphocytes vs. colorectal neoplastic cells: who is winning the apoptotic battle? Apoptosis. 1997;2:489-493.
25. Rubio CA, Kumagai J, Kanamori T, et al. Apoptosis in flat neoplasias of the colorectal mucosa. In Vivo. 1995;9:173-176.
26. Rubio CA, Kato Y, Hirota T. Intraepithelial lymphocytes in flat colorectal adenomas. In Vivo. 1997;11:393-394.
27. Rubio CA, Jacobsson B, Castaños-Velez E. Cytotoxic intraepithelial lymphocytes in colorectal polyps and carcinomas. Anticancer Res. 1999;19:3221-3227.
28. Shia J, Ellis NA, Paty PB, et al. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol. 2003;27:1407-1417.
29. Smyrk TC, Watson P, Kaul K, et al. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer. 2001;91:2417-2422.
30. Stoffel EM, Syngal S. Adenomas in young patients: what is the optimal evaluation? Am J Gastroenterol. 2005;100:1150-1153.
31. Velayos FS, Allen BA, Conrad PG, et al. Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines. Am J Gastroenterol. 2005;100: 1143-1149.
32. Warusavitarne J, Schnitzler M. The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer. Int J Colorectal Dis. 2007;22:739-748.
33. Watanabe T, Muto T, Sawada T, et al. Flat adenoma as a precursor of colorectal carcinoma in hereditary nonpolyposis colorectal carcinoma. Cancer. 1996;77:627-634.
34. Woerner SM, Kloor M, Mueller A, et al. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas. Oncogene. 2005;24:2525-2535.
35. Yearsley M, Hampel H, Lehman A, et al. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Hum Pathol. 2006;37:831-838.